Kataria Jewellers, Aragen Life Sciences and Sembcorp Green Infra Limited File DRHP for IPOs With SEBI

Aragen Life Sciences Limited, Kataria Dhulchand Pannalal Jewellers Limited, and Sembcorp Green Infra Limited have filed their Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on August 26, 2026, for their proposed initial public offerings (IPOs).

Kataria Dhulchand Pannalal Jewellers IPO - Issue Details

• Issue Type: Book-built Issue (Fresh Issue Only)
• Total Issue Size: Up to 1.60 crore equity shares
• Fresh Issue: Up to 1.60 crore equity shares
• Offer for Sale (OFS): Not Applicable
• Face Value: ₹10 per equity share
• Listing: BSE, NSE
• Book Building Lead Managers: Smart Horizon Capital Advisors Private Limited
• Registrar: Bigshare Services Private Limited

Utilisation of Kataria Dhulchand Pannalal Jewellers IPO Proceeds

The Company proposes to use the net proceeds from the fresh issue towards

• Funding capital expenditure towards the establishment of two new stores, one in Kota, Rajasthan and the other in Ujjain, Madhya Pradesh.
• Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company
• General corporate purposes.

About Kataria Dhulchand Pannalal Jewellers Limited

Incorporated in 1996, Kataria Jewellers Limited is an organised jewellery retailer operating under the Kataria Jewellers brand, with its presence primarily concentrated in Madhya Pradesh. The company offers a wide range of gold, platinum, diamond, and silver jewellery, including bridal collections, daily-wear ornaments, bullion, and silver articles across multiple price points.

In addition to its retail business, the company also supplies jewellery to other jewellery retailers. It reported a strong operating revenue CAGR of 76.77% between FY2024 and FY2026.

Key Financial Highlights

Aragen Life Sciences IPO - Issue Details

• Issue Type: Book-built Issue (Fresh Issue + OFS)
• Total Issue Size: To be announced
• Fresh Issue: Up to ₹800.00 crore
• Offer for Sale (OFS): Up to 2.73 crore equity shares
• Face Value: ₹10 per equity share
• Listing: BSE, NSE
• Book Building Lead Managers: Axis Capital Limited, Citigroup Global Markets India Private Limited, Goldman Sachs (India) Securities Private Limited, JM Financial Limited
• Registrar: KFin Technologies Limited

Explore other Upcoming IPOs on BSE and NSE.

Utilisation of Aragen Life Sciences IPO Proceeds

The Company proposes to use the net proceeds from the fresh issue towards

• Repayment and/or pre-payment, in part or full, of certain borrowings availed by the company and its material subsidiaries 
• Capital expenditure to be incurred by the company for purchase of new equipment and machinery for the facilities in Hyderabad
• Capital expenditure to be incurred by one of its material subsidiaries, namely, Aragen Biologics Private Limited for the facility in Bengaluru towards purchase of new equipment and machinery for the following: 
• Expansion of biologics drug substance capacity (“Drug Substance Expansion”);
• Establishment of biologics drug product fill and finish capability (“Fill and Finish Line Establishment”)
• General corporate purposes

About Aragen Life Sciences Limited

Incorporated in 2000, Aragen Life Sciences Limited is a fully integrated contract research, development and manufacturing organisation (CRDMO) providing end-to-end drug discovery, development, and manufacturing services for small molecules and biologics. It serves global pharmaceutical and biotechnology companies across the entire drug development lifecycle.

With over 25 years of operations, the company served 591 customers across the US, Europe, Japan, India, and APAC in Fiscal 2026. According to the F&S Report, it is the largest Indian CRDMO by the number of solutions offered across the drug development value chain.

Key Financial Information

Sembcorp Green Infra IPO - Issue Details

• Issue Type: Book-built Issue (Fresh Issue Only)
• Total Issue Size: Up to ₹3,750.00 crore
• Fresh Issue: Up to ₹3,750.00 crore
• Offer for Sale (OFS): Not Applicable
• Face Value: ₹10 per equity share
• Listing: BSE, NSE
• Book Building Lead Managers: Axis Capital Limited, Citigroup Global Markets India Private Limited, CLSA India Private Limited, HSBC Securities and Capital Markets (India) Private Limited, ICICI Securities Limited, IIFL Capital Services Limited, Kotak Mahindra Capital Company Limited
• Registrar: MUFG Intime India Private Limited

Explore other Upcoming IPOs on BSE and NSE.

Utilisation of Sembcorp Green Infra IPO Proceeds

The Company proposes to use the net proceeds from the fresh issue towards

• Repayment and/or prepayment, in full or in part, of certain borrowings availed of by the company and certain of its subsidiaries 
• General corporate purposes.

About Sembcorp Green Infra Limited

Sembcorp Green Infra Limited is a renewable independent power producer (IPP) engaged in developing, operating, and maintaining utility-scale wind, solar, hybrid, and battery energy storage projects across India. As of March 31, 2026, it ranked among the top 10 largest renewable IPPs in India by operational capacity, according to the CRISIL Report.

The company operates a portfolio of 105 renewable projects across 13 states and union territories, including 84 operational and 21 under-construction projects. As of March 31, 2026, it had 3.60 GW of operational capacity and an additional 4.04 GW/GWh under construction, comprising renewable energy and battery storage capacity.

Key Financial Information

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory. 

To read the RA disclaimer, please click here.